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Abstract
Previous studies have shown a positive association between chronic typhoid carriage and biliary cancers. We
compared serum Salmonella enterica serovar Typhi antibody titers between biliary tract cancer cases, biliary stone
cases without evidence of cancer, and healthy subjects in a large population-based case-control study in Shanghai,
China.
Participants included 627 newly diagnosed primary biliary tract cancer patients; 1,037 biliary stone cases (774
gallbladder and 263 bile-duct) and 959 healthy subjects without a history of cancer, randomly selected from the
Shanghai Resident Registry.
Overall only 6/2,293 (0.26%) were Typhi positive. The prevalence of Typhi was 1/457 (0.22%), 4/977 (0.41%), and 1/
859 (0.12%) among cancer cases, biliary-stone cases, and population controls, respectively.
We did not find an association between Typhi and biliary cancer in Shanghai, due to the very low prevalence of
chronic carriers in this population.
The low seroprevalence of S. Typhi in Shanghai is unlikely to explain the high incidence of biliary cancers in this
population.
Biliary tract cancers, encompassing tumors of the gall-
bladder, extrahepatic bile ducts, and ampulla of Vater,
are rare but highly fatal. Other than an association with
a history of gallstones, the etiology of biliary tract cancer
is obscure [1]. Several studies in India, a high-risk popu-
lation for gallbladder cancer, have reported an associa-
tion between chronic carriage of typhoid and biliary
tract cancer [2,3]. Typhoid fever is caused by Salmonella
enterica serovar Typhi, which can result in chronic
typhoidal cholesystitis. About 3-4% of patients with
acute Typhi infection become chronic, asymptomatic
carriers [4]. To examine the relationship between
chronic typhoid infection and biliary tract cancer, we
compared serum antibodies to the Vi antigen of serovar
Typhi, using the indirect hemagglutination (IHA) assay
[5] between biliary tract cancer cases, biliary stone cases
without evidence of cancer, and healthy subjects ran-
domly selected from the general population, in a large
population-based case-control study in Shanghai, China.
Details of the study have been reported elsewhere [6].
Briefly, between 1997 and 2001, using a rapid reporting
system established in 42 collaborating hospitals in
Shanghai, we enrolled 627 patients newly diagnosed
with primary biliary tract cancer (ICD9 156), 1,037 bili-
ary stone cases (774 gallbladder and 263 bile-duct) fre-
quency-matched to cancer cases on age (5-year
intervals), gender, and hospital, and 959 healthy subjects
without a history of cancer, randomly selected from the
Shanghai Resident Registry and frequency-matched to
cancer cases on age (5-year intervals) and gender.
Ninety-five percent of the eligible cases and 82% of the
eligible controls participated in the study. The study
protocol was approved by the Institutional Review
Boards of the U.S. National Cancer Institute and the
Shanghai Cancer Institute. All subjects provided written
informed consent.
Determination of antibody status to the Vi capsular
polysaccharide antigen of Typhi was assessed at the Cen-
ters for Disease Control and Prevention, Atlanta, GA.
Titers ≥160 were defined as positive for chronic typhoid
infection. For quality control, 30 samples were blindly
retested; concordance of these samples was 100%.
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any medium, provided the original work is properly cited.We assessed the association of chronic typhoid infec-
tion with biliary tract cancer and stones by case-control
status (i) overall, and (ii) by anatomic sub-site. Univariate
and multivariate odds ratios and 95% confidence intervals
were calculated, using maximum likelihood methods.
The characteristics of study subjects are shown in
Table 1. Cancer cases (regardless of sub-site) were more
likely to have gallstones compared with cancer-free con-
trols. Table 2 shows the prevalence of chronic typhoid
infection by subject status. Of the 2,293 subjects, only 6
( 0 . 2 6 % )w e r ep o s i t i v ea t≥160 titer. Four additional par-
ticipants (0.17%) were marginally positive (≥80 titer).
The prevalence of Typhi was 1/457 (0.22%), 4/977
(0.41%), and 1/859 (0.12%) among cancer cases, biliary-
stone cases, and population controls, respectively.
The low prevalence of chronic Typhi carriers in
Shanghai largely explains the lack of association between
biliary cancer and chronic carriage of Typhi in our
study, suggesting that the rise in biliary tract cancer in
Shanghai is likely due to other environmental or infec-
tious agents. Biliary tract cancer is ranked 15
th in cancer
incidence in China, which is similar to India (ranked
14
th) and Bangladesh (ranked 12
th). While it is hard to
estimate incidence of typhoid fever, China is classified
as a medium typhoid fever incidence country, compared
with India which is classified as a high typhoid fever
incidence country [7]. Thus, the very low prevalence of
chronic typhoid carriage observed is consistent with the
lower prevalence of acute typhoid fever reported in
China compared with India and Pakistan [8], where high
prevalence of Typhi chronic carriage has been reported
(~2%). Misclassification of Typhi in cases and controls,
due to the lower assay performance in a population
where typhoid infection is rare (thus with lower titers
among infected), is possible, although such misclassifica-
tion should be non-differential among cases and con-
trols. While the IHA assay has been well validated in
high-prevalence chronic carriage settings, such as India,
in a study from Vietnam, an area with high prevalence
of acute typhoid fever, very low rates of serologic posi-
tivity among the general population were found [9], sug-
gesting that the Vi-antibody test may be a less useful
tool for detection of chronic carriage of Typhi in low-
prevalence chronic carriage settings.
Our study is the largest population-based study of bili-
ary tract cancer. With nearly complete case ascertain-
ment and a high response rate, selection bias is minimal
in the study. Misclassification of the outcome (cancer
and stones) is also minimal, due to the stringent case
confirmation.
In summary, due to the very low prevalence of chronic
S. typhi carriers in this population, we were unable to
evaluate chronic Typhi carriage and biliary cancer in
Shanghai. In populations where chronic carriage of
Typhi is rare, a much larger sample size and a more
sensitive assay are needed to confirm the typhoid
hypothesis. However, we are not able to rule out the
possibility that chronic typhoid infection is associated
with biliary tract cancer in populations with frequent
outbreaks or a high prevalence of typhoid fever.
Table 1 Selected characteristics of cases and controls, Shanghai, China
Biliary Tract Cancer Biliary Stones
Characteristics Controls Gallbladder Extrahepatic Bile Duct Ampulla of Vater Gallbladder Stones Bile Duct Stones
N%N % N % N % N % N %
Total 859 100.0 262 100.0 140 100.0 55 100.0 728 100.0 249 100.0
Age
<55 113 13.2 36 13.7 21 15.0 5 9.1 230 31.6* 56 22.5*
55 - 64 247 28.8 64 24.4 37 26.4 13 23.6 207 28.4 75 30.1
≥65 499 58.1 162 61.8 82 58.6 37 67.3 291 40.0 118 47.4
Sex
Male 335 39.0 72 27.5* 84 60.0* 30 54.6* 250 34.3* 120 48.2
Female 524 61.0 190 72.5 56 40.0 25 45.5 478 65.7 129 51.8
Education (% > Middle school) 293 34.1 57 21.8 45 32.4 16 29.1 313 43.0 94 37.8
Smoking (%)† 259 30.2 69 26.4 63 45.0* 25 45.5* 177 24.3* 92 37.0
Alcohol Use (%)‡ 177 20.6 42 16.0 45 32.1* 14 25.5 110 15.1* 48 19.4
Diabetes (%) 71 8.3 34 13.0* 12 8.6 3 5.5 78 10.7* 29 11.7*
Hypertension (%) 360 41.9 94 35.9 41 29.3* 14 25.5* 249 34.2 70 28.1*
Gallstones (%) 150 17.5 222 84.7* 93 66.4* 29 52.7* - - - -
Body Mass Index (% ≥25.0) 251 29.3 104 39.9 32 22.9 19 34.6 271 37.3 90 36.3
* Chi-sq test comparing cases and controls, p < 0.05
† Current smokers, defined as those who were smoking cigarettes regularly at the time of interview
‡ Current drinkers, defined as those drinking alcohol regularly at the time of interview
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affecting 15% of the population, and that over 17 million
people worldwide are affected by typhoid fever, the role
of Typhi infection in the development of gallstones and
biliary tract cancer needs further clarification.
Acknowledgements
We thank Jie Deng, Jiarong Cheng, Lu Sun, Kai Wu, and the staff at the
Shanghai Cancer Institute for data collection, specimen collection, and
processing, surgeons at the collaborating hospitals for data collection, and
local pathologists for pathology review; Shelley Niwa of Westat for data
preparation and management; and Janis Koci of the Scientific Applications
International Corporation for management of the biological samples.
This project has been funded in whole or in part with federal funds from
the National Cancer Institute, National Institutes of Health, under contract
N01-CO-12400. The content of this publication does not necessarily reflect
the reviews or policies of the Department of Health and Human Services,
nor does mention of trade names, commercial products, or organizations
imply endorsement by the U.S. Government.
Author details
1Division of Cancer Epidemiology and Genetics, National Cancer Institute,
Bethesda, Maryland, USA.
2Department of Epidemiology, Shanghai Cancer
Institute, Shanghai Cancer Institute, Shanghai, China.
3Department of
Epidemiology, University of Washington, Seattle, WA, USA.
4Department of
Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX
USA.
5Department of Surgery, Zhongshan Hospital, Shanghai Medical
University, Shanghai, China.
6Department of Epidemiology and Biostatistics,
University of Pennsylvania, Philadelphia, PA, USA.
7Diarrheal Diseases
Epidemiology Section, Foodborne and Diarrheal Diseases Branch, Centers for
Disease Control and Prevention, Atlanta, GA, USA.
Authors’ contributions
MS: responsible for analysis and manuscript preparation. YTG: PI of the study
(China), responsible for study design, subject recruitment, conduct of the
study and all aspects of the study in China. BSW: surgeon, responsible for
patient recruitments, diagnosis of cancer, and treatment of cases. EM and JP:
- responsible for development of assays, QC of assays, running of assays and
accuracy of results. AR: study pathologist. Responsible for the diagnosis of all
cancer cases, QC, and review of slides. LS and SQ - responsible for the
conduct of the study, data management, specimen management and
retrieval, implementation of QCs. JC: contributed to the statistical analysis
and design of the study. AH - responsible for all aspects of the study,
including study design, subject recruitment, conduct of the study, analysis,
and preparation of the manuscript All authors contributed to data
interpretation and read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 13 December 2010 Accepted: 2 May 2011
Published: 2 May 2011
References
1. Hsing AW, Rashid A, Devesa SS, Fraumeni JF Jr: Biliary tract cancer. In
Cancer Epidemiology and Prevention. Edited by: Schottenfeld D, Fraumeni JF
Jr. Oxford University Press; 2006:787-800.
2. Dutta U, Garg PK, Kumar R, Tandon RK: Typhoid carriers among patients
with gallstones are at increased risk for carcinoma of the gallbladder.
Am J Gastroenterol 2000, 95:784-787.
3. Vaishnavi C, Kochhar R, Singh G, Kumar S, Singh S, Singh K: Epidemiology
of typhoid carriers among blood donors and patients with biliary,
gastrointestinal and other related diseases. Microbiol Immunol 2005,
49:107-112.
4. Lin FY, Becke JM, Groves C, Lim BP, Israel E, Becker EF, Helfrich RM,
Swetter DS, Cramton T, Robbins JB: Restaurant-associated outbreak of
typhoid fever in Maryland: identification of carrier facilitated by
measurement of serum Vi antibodies. J Clin Microbiol 1988, 26:1194-1197.
5. Lanata CF, Levine MM, Ristori C, Black RE, Jimenez L, Salcedo M, Garcia J,
Sotomayor V: Vi serology in detection of chronic Salmonella typhi
carriers in an endemic area. Lancet 1983, 2:441-443.
6. Gao YT, Han TQ, Rashid A, Sakoda LC, Wang BS, Shen MC, Zhang BH,
Niwa S, Chen J, Fraumeni JF Jr: Gallstones and the risk of biliary tract
cancer: a population-based study in China. Br J Cancer 2007,
97:1577-1582.
7. Crump JA, Luby SP, Mintz ED: The global burden of typhoid fever. Bull
World Health Organ 2004, 82(5):346-53.
8. Acosta CJ, Danovaro-Holliday MC, Baiqing D, Bhattacharya SK, Agtini MD,
Bhutta ZA, Canh DG, Ali M, Shin S, Wain J, Page AL, Albert MJ, Farrar J, bu-
Elyazeed R, Pang T, Galindo CM, vonSeidlein L, Clemens JD: A study of
typhoid fever in five Asian countries: disease burden and implications
for controls. Bull World Health Organ 2008, 86:260-268.
9. Gupta A, My Thanh NT, Olsen SJ, Sivapalasingam S, My Trinh TT, Phuong
Lan NT, Hoekstra RM, Bibb W, Minh NT, Danh TP, Cam PD, Mintz ED:
Evaluation of community-based serologic screening for identification of
chronic Salmonella typhi carriers in Vietnam. Int J Infect Dis 2006,
10:309-314.
doi:10.1186/1750-9378-6-6
Cite this article as: Safaeian et al.: Chronic typhoid infection and the risk
of biliary tract cancer and stones in Shanghai, China. Infectious Agents
and Cancer 2011 6:6.
Table 2 Odds ratios* (ORs) and 95% confidence intervals (CI) for cancers of the biliary tract cancer and stones in
relation to chronic typhoid infection, Shanghai China
Biliary Tract Cancer Biliary Stones
Controls
a Total Gallbladder Extrahepatic Bile
Duct
Ampulla of
Vater
Controls
b Biliary
Stones
Gallbladder
Stones
Bile Duct
Stones
Typhoid N N OR (95%CI) N OR
(95%CI)
N OR (95%CI) N OR
(95%CI)
NN O R
(95%CI)
N OR (95%CI) N OR
(95%CI)
Total 859 457 262 140 55 654 977 728 249
Negative
c 858 456 262 139 55 654 973 726 247
Positive
≥1:160
d 1 1 1.9 (0.1-31.1) 0 1 5.9 (0.4-95.2) 0 0 4 2 2
*OR = odds ratio, adjusted for age and for level of education
a N = 800 for gallbladder cancer controls due to exclusion of those with history of cholecystectomy
b Controls with gallstones were excluded.
c Negative defined as no hemagglutination at <160.
d Positive defined as hemagglutination at ≥ 160.
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